Results 71 to 80 of about 13,791 (225)

Causal effects of gut microbiota on risk of interstitial cystitis: a two-sample Mendelian randomization study

Frontiers in Microbiology
BackgroundThe correlation between gut microbiota and interstitial cystitis has garnered significant attention in previous studies. Nevertheless, the causal relationship between them remains to be clarified.MethodsGenetic variation serves as a tool in ...
Jianguo Gao, Sihai Shao, Yuefan Shen
doaj   +1 more source

The Antipsychotic Aripiprazole Induces Cytotoxicity in Bladder Cancer Cells While Preserving Urothelial and Bladder Function

Pharmacology Research &Perspectives, Volume 14, Issue 3, June 2026.
Current bladder cancer therapies can cause toxicity and bladder dysfunction. Brief intravesical‐like aripiprazole exposure reduced bladder cancer cell viability and was associated with redox stress and caspase‐3 activation, while ex vivo findings suggested preserved bladder structure and function, warranting further investigation as a potential ...
Liam A. O'Callaghan, Katie Powell, Russ Chess‐Williams, Catherine McDermott   +3 more
wiley   +1 more source

Evaluation of prostaglandin E2 and E-series prostaglandin receptor in patients with interstitial cystitis

, 2015
CC-BY-NC-NDPURPOSE: We evaluated PGE2 and EP receptor in patients with interstitial cystitis. MATERIALS AND METHODS: Enrolled in the study were 20 female patients with interstitial cystitis (11 with and 9 without Hunner lesions), 9 female controls with
Furuno, Tsuyoshi, 古野, 剛史, Kakizaki, Hidehiro, Ameda, Kaname, 岡田, 啓希, 伊達, 一郎, 柿崎, 秀宏, ワダ, ナオキ, オカダ, ヒロキ, カキザキ, ヒデヒロ, フルノ, ツヨシ, Date, Ichiro, 飴田, 要, Okada, Hiroki, アメダ, カナメ, ダテ, イチロウ, 和田, 直樹, Wada, Naoki   +17 more
core   +1 more source

The efficacy and Safety of Intravesical Bacillus-Calmette-Guerin in the Treatment of Female Patients with Interstitial Cystitis: A double-blinded Prospective Placebo Controlled Study

Urology Journal, 2004
Purpose: To evaluate the efficacy and safety of intravesical Bacillus Calmette-Gurein injection in the treatment of female patients with interstitial cystitis.
AA Khezri, M Heidari, Darioush Irani
doaj  

Co-morbidities of Interstitial Cystitis

Frontiers in Neuroscience, 2012
Introduction: This study aimed to estimate the proportion of patients with Interstitial Cystitis/Painful Bladder Syndrome (IC/BPS) with systemic dysfunction associated co-morbidities such as irritable bowel syndrome (IBS) and fibromyalgia (FM). Material
Gisela eChelimsky, Elizabeth eHeller, C. Anthony eBuffington, Raymond eRackley, Di eZhang, Thomas eChelimsky   +5 more
doaj   +1 more source

Checkpoint inhibitors, obinutuzumab plus PET‐adapted ultra‐low dose nodal radiotherapy yield high efficacy in treatment‐naïve follicular lymphoma: Results from the phase II ‘FLUORO’ study

British Journal of Haematology, Volume 208, Issue 6, Page 2026-2035, June 2026.
Summary Follicular lymphoma (FL) first‐line chemoimmunotherapy yields high efficacy but serious toxicity in 65% of patients. In high tumour burden treatment‐naïve FL, we aimed to exploit known immunostimulatory and cytotoxic properties of combination checkpoint inhibition (atezolizumab) and obinutuzumab (6 cycles) with positron emission tomography (PET)
Arina Martynchyk, Geoffrey Chong, Richard Khor, Denise Lee, Sze Ting Lee, Andrew M. Scott, Anneke C. Grobler, Belinda A. Campbell, Thanuja Thachil, Kate Manos, Genevieve Douglas, Alexandra Romano, Jodie B. Palmer, Melinda Burgess, Colm Keane, Eliza A. Hawkes   +15 more
wiley   +1 more source

Interstitial cystitis is bladder pain syndrome with Hunner's lesion

, 2014
The contents and understanding of the term, interstitial cystitis, have undergone major changes during the past 100 years, moving from a chronic, true inflammatory bladder disorder to an extensive syndrome with lower urinary tract pain.
Peeker, Ralph,, Fall, Magnus,, Logadottir, Yr,   +2 more
core   +1 more source

Pulsed Electromagnetic Field Therapy as a Complementary Alternative for Chronic Pelvic Pain Management in an Interstitial Cystitis/Bladder Pain Syndrome Patient

Case Reports in Urology, 2019
Interstitial cystitis/bladder pain syndrome is a chronic pelvic pain condition with no known etiology that affects millions of women and men in the United States.
Tyler L. Overholt, Christina Ross, Robert J. Evans, Stephen J. Walker   +3 more
doaj   +1 more source

Downstream Treatment Burden and Health‐Care Utilization Following Initiation of GLP‐1 Receptor Agonists or SGLT2 Inhibitors in Type 2 Diabetes

Diabetes, Obesity and Metabolism, Volume 28, Issue 6, Page 5163-5173, June 2026.
ABSTRACT Aims Glucagon‐like peptide‐1 (GLP‐1) receptor agonists and sodium–glucose cotransporter 2 (SGLT2) inhibitors are widely used for the treatment of type 2 diabetes, yet their downstream consequences in routine clinical practice remain incompletely characterized.
Yazan Alhamdan, Jason C. Hsu, Christine Y. Lu   +2 more
wiley   +1 more source

Pathophysiology of interstitial cystitis [PDF]

International Journal of Urology, 2019
AbstractInterstitial cystitis/bladder pain syndrome is a chronic pain syndrome whose causes remains elusive with no generally accepted treatment. A hallmark of functional pain syndromes such as interstitial cystitis/bladder pain syndrome is pain in the absence of demonstrable pathology of the viscera or associated nerves.
openaire   +2 more sources